BREAKING: Hims & Hers Earnings Breakdown | The Growth Nobody's Talking About

Summary

Key Points

• —Hims and Hers reported 4% growth year-over-year, which may seem slow, but the company is expected to pick up growth in the second half of the year. 1:56
• —The company's subscriber number grew 9% year-over-year, but the average revenue per subscriber declined 6% due to less money spent per subscriber. 2:40
• —The company's guidance for the full year was increased to $2.8 billion to $3 billion in revenue, but adjusted EBITA was slightly declined due to increased spending for growth. 4:47
• —Hims and Hers is diversifying its business with more products and modalities, which is expected to drive long-term growth. 5:34
• —Management believes the company is on track to hit its long-term target of $6.5 billion in revenue and $1.3 billion in adjusted EBITA by 2030. 6:23
• —The company is becoming more of a platform company, expanding into new markets and building strategic relationships, which is expected to drive growth. 6:45
• —Hims and Hers has a strong balance sheet with $751 million in cash and is generating positive cash flow from operations. 9:26
• —The company's strategy to become a healthcare platform is intact, and the recent quarterly report does not challenge the long-term thesis. 9:36
• —The company's growth is expected to accelerate in the second half of the year, driven by new branded products and potential tailwinds from peptides. 10:57